Achievement of rapid complete remission in an 87-year-old female patient with azacytidine-venetoclax for blastic plasmacytoid dendritic cell neoplasm

Ann Hematol. 2022 Jun;101(6):1347-1349. doi: 10.1007/s00277-021-04718-2. Epub 2022 Mar 6.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Azacitidine / therapeutic use
  • Bridged Bicyclo Compounds, Heterocyclic
  • Dendritic Cells
  • Female
  • Humans
  • Myeloproliferative Disorders*
  • Skin Neoplasms* / drug therapy
  • Sulfonamides

Substances

  • Bridged Bicyclo Compounds, Heterocyclic
  • Sulfonamides
  • Azacitidine
  • venetoclax